Clinical Trial Update: Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples

View source ↗

Summary

This clinical trial update reports the prospective evaluation of the StatusFirst CHF NT-proBNP device in human whole blood and plasma for congestive heart failu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Nanogen, Inc. | Conditions: Congestive Heart Failure (CHF) | Status: COMPLETED